EPHX2 and obesity due to melanocortin 4 receptor deficiency: Given the involvement of sEH in inflammation and also the increased activity of sEH during obesity and metabolic dysfunction, we hypothesised that increasing EET concentrations by sEH inhibition may be important in controlling obesity and the symptoms of the metabolic syndrome.